Patient Portal Update: MyCarePlus is being replaced with Ontada Health. Learn More
HIPAA Alert: Potential Data Breach. Learn More
USOR 23243 - Ph2 Randomized dose-optimization study of alisertib in patients with SCLC (PB-8237)
A PHASE 2 STUDY OF ALISERTIB IN PATIENTS WITH EXTENSIVE SMALL CELL LUNG CANCER (PUMA-ALI-4201)
Disease Types: Lung - Small Cell Lung
Available at: Arlington Heights, Niles